Evidence map›Paper›PMID 32490143›Full record

ArticleAlzheimer's & dementia (New York, N. Y.)2020

Transcranial stimulation in frontotemporal dementia: A randomized, double-blind, sham-controlled trial.

Alberto Benussi, Valentina Dell'Era, Maura Cosseddu, Valentina Cantoni, Maria Sofia Cotelli, Maria Cotelli, Rosa Manenti, Luisa Benussi, Chiara Brattini, Antonella Alberici and 1 more

Open access · goldAbstract read
In one paragraph

Article in Alzheimer's & dementia (New York, N. Y.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 3 pooled it
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 3 syntheses or guidelines pooled it, 51 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Frontotemporal Dementia, Where Do We Stand? A Narrative Review.International journal of molecular sciences · 2023
    Review
  17. New Approaches to the Treatment of Frontotemporal Dementia.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2023
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Alberto BenussiNeurology Unit Department of Clinical and Experimental Sciences University of Brescia Brescia Italy.ORCID https://orcid.org/0000-0002-8703-6940
Valentina Dell'EraNeurology Unit Department of Clinical and Experimental Sciences University of Brescia Brescia Italy.
Maura CossedduNeurology Unit Spedali Civili Hospital Brescia Italy.
Valentina CantoniNeurology Unit Department of Clinical and Experimental Sciences University of Brescia Brescia Italy.
Maria Sofia CotelliNeurology Unit Valle Camonica Hospital Esine Brescia Italy.
Maria CotelliNeuropsychology Unit IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli Brescia Italy.
Rosa ManentiNeuropsychology Unit IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli Brescia Italy.
Luisa BenussiMolecular Markers Laboratory IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli Brescia Italy.
Chiara BrattiniNeurology Unit Department of Clinical and Experimental Sciences University of Brescia Brescia Italy.
Antonella AlbericiNeurology Unit Spedali Civili Hospital Brescia Italy.
Barbara BorroniNeurology Unit Department of Clinical and Experimental Sciences University of Brescia Brescia Italy.
University of Brescia · ITCentro San Giovanni di Dio Fatebenefratelli · ITAzienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionFrontotemporal dementia (FTD) is a progressive disease for which no curative treatment is currently available. We aimed to determine whether transcranial direct current stimulation (tDCS) can modulate intracortical connectivity and improve cognition in symptomatic FTD patients and presymptomatic FTD subjects.

methodsWe performed a double-blind, randomized, sham-controlled trial with anodal tDCS or sham stimulation over the left prefrontal cortex in 70 participants (15 presymptomatic and 55 symptomatic FTD).

resultsWe observed a significant increase of intracortical connectivity (short interval intracortical inhibition and facilitation) and improvement in clinical scores and behavioral disturbances in both symptomatic FTD patients and presymptomatic carriers after real tDCS but not after sham stimulation. DISCUSSION: A 2-weeks' treatment with anodal left prefrontal tDCS improves symptoms and restores intracortical inhibitory and excitatory circuits in both symptomatic FTD patients and presymptomatic carriers. tDCS might represent a promising future therapeutic and rehabilitative approach in patients with FTD.

Indexed as

clinical trialfrontotemporal dementiagranulinpresymptomaticshort interval intracortical inhibitiontranscranial direct current stimulationtranscranial magnetic stimulation

Identifiers

PMID32490143
PMCPMC7253155
OpenAlexW3028678099

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.